A recent study looked at whether medications used to treat ADHD improve school achievement. Previous studies that examined that question were mixed.

Patients often come into my office to be “tested for ADHD,” and I explain to them that the diagnosis depends on a thorough clinical interview. Nonetheless, rating scales can be useful.

In 2006, an FDA panel recommended all manufacturers of stimulants to add a “black box” warning about an increased risk of “serious cardiovascular events.”

...

Omega-3 fatty acids have been extolled as a treatment for everything from depression to high blood pressure. But how do they stack up for ADHD?

Head injuries occur in 110 to 400 out of every 100,000 adults each year, but are much more common in children—around 692 per 100,000 children younger than 15. Mild traumatic brain injury (TBI) occurs in 75% to 85% of these cases.

If you want to watch a new drug wend its way to market, you might start watching the literature for ABT-809, a nicotinic receptor partial agonist and proposed novel approach to the treatment of ADHD.

Sometimes complex motor tics and OCD compulsions can be difficult to differentiate, since both are related to urges to perform some type of activity or movement.

Advocates tout restricted diets for the treatment of everything from migraines to autism.

The gold standards of treatment for ADHD are the stimulants amphetamine and methylphenidate. They are old friends, having been used for decades, and there is a wealth of patient experience with them. Although we use them all the time, an occasional review of the tools in our toolbox is always helpful.